Atherosclerosis and interferon-γ: New insights and therapeutic targets

Trends in Cardiovascular Medicine

Volumn 24, Issue 1, 2014, Pages 45-51

  Voloshyna, Iryna ^a   Littlefield, Michael J ^a   Reiss, Allison B ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE; LIPID; MACROPHAGE ACTIVATING FACTOR; MICRORNA 155; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; STAT1 PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ARTERY ENDOTHELIUM; ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHRONIC INFLAMMATION; CYTOKINE RELEASE; CYTOSOL; ENDOTHELIUM CELL; FOAM CELL; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; INNATE IMMUNITY; LIPID TRANSPORT; MACROPHAGE; MEDIATOR RELEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ATHEROSCLEROSIS; CARDIOVASCULAR AGENTS; DRUG DESIGN; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION;

EID: 84890788978     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.06.003     Document Type: Review

References (48)

1. Amento E.P., Ehsani N., Palmer H., Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arteriosclerosis Thrombosis and Vascular Biology 1991, 11:1223-1230.
2. Azari B.M., Marmur J.D., Salifu M.O., Ehrlich Y.H., Kornecki E., Babinska A. Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines. Journal of Translational Medicine 2011, 9:98.
3. Barnholt K.E., Kota R.S., Aung H.H., Rutledge J.C. Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation. Journal of Immunology 2009, 183(10):6767-6777.
4. Billiau A., Matthys P. Interferon-gamma: a historical perspective. Cytokine and Growth Factor Reviews 2009, 20(2):97-113.
5. Clarke M.C., Figg N., Maguire J.J., Davenport A.P., Goddard M., Littlewood T.D., et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nature Medicine 2006, 12:1075-1080.
6. Chung E.Y., Kim B.H., Hong J.T., Lee C.K., Ahn B., Nam S.Y., et al. Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation. Journal of Nutritional Biochemistry 2011, 22(10):902-909.
7. Dusting G.J., Selemidis S., Jiang F. Mechanisms for suppressing NADPH oxidase in the vascular wall. Memorias do Instituto Oswaldo Cruz 2005, 100(suppl 1):97-103.
8. Grewal T., Priceputu E., Davignon J., Bernier L. Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene. Arteriosclerosis Thrombosis and Vascular Biology 2001, 21(5):825-831.
9. Hao X.R., Cao D.L., Hu Y.W., Li X.X., Liu X.H., Xiao J., et al. IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis 2009, 203(2):417-428.
10. Heistad D.D., Wakisaka Y., Miller J., Chu Y., Pena-Silva R. Novel aspects of oxidative stress in cardiovascular diseases. Circulation Journal 2009, 73:201-207.
11. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104:2673-2678.
12. Huang R.S., Hu G.Q., Lin B., Lin Z.Y., Sun C.C. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. Journal of Investigative Medicine 2010, 58:961-967.
13. Inagaki Y., Yamagishi S., Amano S., Okamoto T., Koga K., Makita Z. Interferon-gamma-induced apoptosis and activation of THP-1 macrophages. Life Sciences 2002, 71(21):2499-2508.
14. Kzhyshkowska J., Neyen C., Gordon S. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 2012, 217(5):492-502.
15. Lechleitner B., Gille J., Johnson D.R., Petzelbauer P. Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon related factor 1-dependent pathway. Journal of Experimental Medicine 1998, 187:2023-2030.
16. 3 adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling. Immunobiology 2011, 216(9):997-1003.
17. Li N., McLaren J.E., Michael D.R., Clement M., Fielding C.A., Ramji D.P. ERK is integral to the interferon-gamma-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages. Journal of Immunology 2010, 185:3041-3048.
18. Libby P. Inflammation in atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology 2012, 32(9):2045-2051.
19. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003, 169:203-214.
20. McLaren J.E., Ramji D.P. Interferon gamma: a master regulator of atheroslerosis. Cytokine and Growth Factor Reviews 2009, 20:125-135.
21. Moore K.J., Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011, 145:341-355.
22. Munn D.H., Beall A.C., Song D., Wrenn R.W., Throckmorton D.C. Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gamma. Journal of Experimental Medicine 1995, 181(1):127-136.
23. Nazari-Jahantigh M., Wei Y., Noels H., Akhtar S., Zhou Z., Koenen R.R., et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. Journal of Clinical Investigation 2012, 122:4190-4202.
24. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiological Reviews 2004, 84:767-801.
25. Paulnock D.M., Demick K.P., Coller S.P. Analysis of interferon-gamma-dependent and -independent pathways of macrophage activation. Journal of Leukocyte Biology 2000, 67(5):677-682.
26. Reiss A.B., Awadallah N.W., Malhotra S., Montesinos M.C., Chan E.S., Javitt N.B. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. Journal of Lipid Research 2001, 42(11):1913-1922.
27. Reiss A.B., Patel C.A., Rahman M.M., Chan E.S., Hasneen K., Montesinos M.C., et al. Interferon-γ impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. Medical Science Monitor 2004, 10:BR420-BR425.
28. Rekhter M.D., Zhang K., Narayanan A.S., Phan S., Schork M.A., Gordon D. Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. American Journal of Pathology 1993, 143:1634-1648.
29. Rimbach G., Valacchi G., Canali R., Virgili F. Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Molecular Cell Biology Research Communications 2000, 3(4):238-242.
30. Rong J.X., Shapiro M., Trogan E., Fisher E.A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(23):13531-13536.
31. Rothenbacher D., Müller-Scholze S., Herder C., Koenig W., Kolb H. Differential expression of chemokines, risk of stable coronary heart disease and correlation with established cardiovascular risk markers. Arteriosclerosis Thrombosis and Vascular Biology 2006, 26:194-199.
32. Schaub F.J., Han D.K., Liles W.C., Adams L.D., Coats S.A., Ramachandran R.K., et al. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nature Medicine 2000, 6(7):790-796.
33. Schroecksnadel K., Frick B., Winkler C., Fuchs D. Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease. Current Vascular Pharmacology 2006, 4:205-213.
34. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nature Medicine 2002, 8:1211-1217.
35. Stokes K.Y., Clanton E.C., Clements K.P., Granger D.N. Role of interferon-gamma in hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation 2003, 107:2140-2145.
36. Sugioka K., Naruko T., Matsumura Y., Shirai N., Hozumi T., Yoshiyama M., et al. Neopterin and atherosclerotic plaque instability in coronary and carotid arteries. Journal of Atherosclerosis and Thrombosis 2010, 17(11):1115-1121.
37. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiological Reviews 2006, 86:515-581.
38. Tenger C., Sundborger A., Jawien J., Zhou X. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells. Arteriosclerosis Thrombosis and Vascular Biology 2005, 25(4):791-796.
39. Tracy R.P., Doyle M.F., Olson N.C., Huber S.A., Jenny N.S., Sallam R., et al. T-helper type 1 bias in healthy people is associated with cytomegalovirus serology and atherosclerosis: the multi-ethnic study of atherosclerosis. Journal of the American Heart Association 2013, 202:e000117.
40. Varinou L., Ramsauer K., Karaghiosoff M., Kolbe T., Pfeffer K., Muller M., et al. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity 2003, 19:793-802.
41. Voloshyna I., Reiss A.B. The ABC transporters in lipid flux and atherosclerosis. Progress in Lipid Research 2011, 50(3):213-224.
42. Voloshyna I., Hai O., Littlefield M.J., Carsons S.E., Reiss A.B. Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPAR-γ and adenosine. European Journal of Pharmacology 2013, 698(1-3):299-309.
43. Wang X.Q., Panousis C.G., Alfaro M.L., Evans G.F., Zuckerman S.H. Interferon-gamma-mediated downregulation of cholesterol efflux and ABC1 expression is by the Stat1 pathway. Arteriosclerosis Thrombosis and Vascular Biology 2002, 22(5):e5-e9.
44. Wågsäter D., Olofsson P.S., Norgren L., Stenberg B., Sirsjö A. The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma. Biochemical and Biophysical Research Communications 2004, 325(4):1187-1193.
45. Whitman S.C., Ravisankar P., Elam H., Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. American Journal of Pathology 2000, 157:1819-1824.
46. Whitman S.C., Ravisankar P., Daugherty A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. Journal of Interferon and Cytokine Research 2002, 22(6):661-670.
47. Wuttge D.M., Zhou X., Sheikine Y., Wagsater D., Stemme V., Hedin U., et al. CXCL16/SR-PSOX is an interferon-{gamma}-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arteriosclerosis Thrombosis and Vascular Biology 2004, 24(4):750-755.
48. Zhang J., Alcaide P., Liu L., Sun J., He A., Luscinskas F.W., et al. Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils. PLoS One 2011, 6(1):e14525.